In this engaging episode we welcome Saurabh Jain, Executive Chairman of Opyl Ltd, to delve into how artificial intelligence is driving transformative changes in the healthcare and biotech sectors. With a career marked by pioneering tech startups and forward-thinking healthcare innovations, Saurabh provides a compelling perspective on the evolving role of AI in global health.

Saurabh Jain is a seasoned leader in technology and healthcare, currently serving as the Executive Chairman of Opyl (ASX: OPL), a company pioneering AI-driven solutions for clinical trials. Appointed to this role on April 30, 2024, Saurabh spearheads Opyl's mission to transform clinical trials through advanced AI technologies. His leadership has been instrumental in fostering innovation and accelerating the global adoption of AI solutions in the healthcare sector.

Throughout his extensive 25-year career, Saurabh has held various senior executive positions, including CEO and Executive Director roles. His experience includes founding Netpro Express, an internet service provider later acquired by Telstra, and serving on multiple ASX boards and private companies. Known for his entrepreneurial acumen and vision, Saurabh has consistently driven transformative change and fostered business growth across industries. His current focus is on expanding Opyl’s global footprint while enhancing the commercialization of its innovative AI solutions.

Saurabh holds a Bachelor of Engineering (Software Engineering), an Executive Master of Business Administration, and a Master of Business Technology from the Australian Graduate School of Management, UNSW. Under his guidance, Opyl has engaged in strategic partnerships, participated in high-profile industry events, and expanded its influence in both the Asia-Pacific region and beyond.

LinkedIn: ⁠https://www.linkedin.com/in/saurabhjain10

Website: ⁠https://opyl.ai

Twitter: https://x.com/OpylAI